Introduction: Toxicities of anti-cancer therapies
Session type: Parallel sessions
Modern anti-cancer therapy - including targeted biological treatments - still carries a significant burden of toxicities which can impact on patients' quality of life and at worst, leads to treatment reduction and may shorten life. The first toxicities to be managed with a scientific approach were infections and chemotherapy induced emesis. In the past decade there has been a leap forward in the understanding of these and other adverse effects of drugs and radiation therapy. The session will present a state of the art overview of supportive care research into mechanisms and management, which will benefit all who deliver anti-cancer treatments.